Orilissa 00074-0039-56
Generic: Elagolix
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 23, 2018
- Listing Expires
- December 31, 2026
- Application
- NDA210450
Need to source Orilissa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Elagolix Sodium | 200 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A Inducers [MoA]Decreased GnRH Secretion [PE]
Selected Package
00074-0039-56Selected4 BLISTER PACK in 1 CARTON (0074-0039-56) / 14 TABLET, FILM COATED in 1 BLISTER PACK
Other packages for this product(1)
1 BLISTER PACK in 1 CARTON (0074-0039-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK